Article Details

Analysts Anticipate Sorrento Therapeutics, Inc. (NASDAQ:SRNE) to Post -$0.20 EPS

Retrieved on: 2021-08-09 09:11:15

Tags for this article:

Click the tags to see associated articles and topics

Analysts Anticipate Sorrento Therapeutics, Inc. (NASDAQ:SRNE) to Post -$0.20 EPS. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 19,409,333 shares of the biopharmaceutical company's stock worth $160,515,000 after purchasing an additional 1,789,655 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up